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ABSTRACT 
BARRIERS IN HYPERTENSION MANAGEMENT AMONG CULTURALLY 
DIVERSE PATIENTS IN AN URBAN URGENT CARE SETTING  
Hypertension is the leading cause of deaths related to cardiovascular disease 
conditions. A vast number of patients are not taking their medications as prescribed by 
the physicians. This non-adherence to hypertensive treatment plans results in increased 
numbers of cases of unstable blood pressure. Medication adherence will help to manage 
the controllable cardiovascular diseases and will automatically decrease the incidences of 
emergent cases in hospitals and urgent care clinics. It will further decrease the costs of 
diagnostic evaluations used during the emergent visits. This decreased patient load in the 
emergency rooms will improve quality patient care. The study timeframe of data 
collection and result analysis was from September 14, 2018 to October 30, 2019. This 
pilot study identified a relationship between medication non-adherence rate and number 
of barriers. The greater the barrier, the higher the non-adherence rate. With the help of 
open-ended questions, the study identified multiple barriers which are consistent with 
medication non-adherence rates.  
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Chapter 1: Introduction 
Heart disease is the leading cause of death and a major risk factor of cardiovascular 
diseases. According to the Centers for Disease Control and Prevention (CDC, 2017), in the 
United States, approximately 75 million adults suffer from hypertension, while about half of that 
number have uncontrolled blood pressure. A common reason for uncontrolled hypertension is 
treatment non-adherence (CDC, 2017). Treatment non-adherence refers to patients not following 
their treatment plans as given by their providers (CDC, 2017).  Non-adherence to medication 
increases the number of hospital admissions, healthcare costs, morbidity, and mortality. In the 
United States, doctors write approximately 3.8 million prescriptions every year, yet 1 in 5 
prescriptions are never filled. Among the filled prescriptions, about 50% are not taken as 
prescribed with regard to dose, frequency, and duration. In light of these factors, promoting and 
facilitating improved medication adherence can ease the economic and health burden that non-
adherence creates (Neiman et al., 2017). 
Background 
Controlling hypertension helps improve patients’ cardiovascular health (Neiman et al., 
2017), but controlling it requires taking prescribed medications consistently. Medication 
adherence can decrease hospital costs by decreasing unnecessary hospital admissions due to 
hypertensive urgency. Medication adherence is a complicated behavior that depends on both 
intentional and unintentional factors. Neimen et al. (2017) identified the following intentional 
factors: (a) cultural beliefs, (b) attitude, (c) not taking medications as prescribed, and (d) 
medication side effects. Unintentional factors include: (a) the need to follow multiple drug 
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regimens, (b) failure to refill medications, and (c) a lack of education related to the medications 
(Neiman et al., 2017). In Neiman et al.’s study, the majority of medication non-adherence 
occurred in patients on multiple drug regimens. However, non-adherence stems from a 
combination of various factors. It occurs when patients fail to start their prescription medications 
on time, fail to incorporate medications into their daily routine, or fail to continue to take their 
medications for their disease condition.  
 A Healthcare Informatics report explained that countries are spending a large amount of 
money to increase patient compliance with medications. If patients start taking medication as 
prescribed, the healthcare industry can save on expenditures such as utilization of health care 
services and cost of patient care in urgent hospitalization visits (Vrijens, Antoniou, Burnier, de la 
Sierra, & Volpe, 2017). Iuga and McGuire (2014) determined that the cost of medication 
adherence related to disease management is less compared to the cost of hospitalization due to 
non-adherence. Medication adherence helps manage controllable diseases and can automatically 
decrease the impact of emergency cases in hospitals and urgent care clinics. In addition, 
medication adherence further decreases the cost of diagnostic evaluations used during emergency 
visits, decreases the patient load in the emergency room, and increases the quality of patient care 
by reducing the number of patients (Iuga & McGuire, 2014). 
Problem Statement 
Many researchers sought to study adherence to hypertensive medication with regard to 
disease management. However, they examined very narrow populations despite the diverse 
population in the United States. In addition, numerous research studies used close-ended 
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questionnaires, which limited patients’ responses related to the problem. In this research study, 
researchers used open-ended questionnaires, which gave the participants’ more freedom to 
express feelings related to the non-adherence of hypertensive medications.  
Holt et al. (2013) conducted telephone interviews and surveys to gather data related to 
barriers in hypertension management that cause non-adherence. Because the telephone 
interviews allowed for only verbal interaction, the researchers could not determine if the 
respondents were the patients themselves or their family members, leading to potentially biased 
results. Therefore, in the completed research study, the researcher collected data at Urban Urgent 
Care during face-to-face encounters with the patients. This approach increased the accuracy of 
the results, as the researcher personally gathered the patients’ responses. Such an approach also 
enhances patients’ confidentiality due to fewer individuals having access to the data. Although 
Tong, Chu, Fang, Wall, and Ayala (2016) sent survey questionnaires through the mail to collect 
patients’ responses, this method excluded the homeless population and those unable to provide 
mailing addresses. This researcher avoided this issue by conducting the study at a physical 
location. The researcher recruited patients during office visits and gathered responses during 
physical encounters. This process decreased the kind of bias found in the studies included in the 
literature review.  
Purpose of the Project 
In this Doctor of Nursing Practice (DNP) project the researcher sought to identify the 
barriers causing non-adherence to treatment plans among individuals 45 to 60 years old. The 
researcher’s goal was to obtain information on cardiovascular health by identifying the barriers 
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causing non-adherence to hypertension treatment plans. Healthy People 2020 has 24 objectives 
and among them is the plan to increase prevention of heart disease and stroke and improve 
patients’ cardiovascular health. Hypertension is one of the underlying causes of cardiovascular 
diseases (CDC, 2017). The identification of barriers revealed the reasons for medication non-
adherence, which will help clinicians work to reduce the non-adherence rate. Mahmoudian, 
Zamani, Tavakoli, Farajzadegan, and Fathollahi-Dehkordi (2017) found that controlling 
hypertension can decrease morbidity and mortality rates related to cardiovascular disease and 
stroke. Medication adherence can also help control hypertension. Medication adherence is a 
complicated behavior that involves patients, family members, providers, and patients’ health 
beliefs (Mahmoudian et al., 2017). It is imperative to educate patients and family members about 
related treatment benefits and uncontrolled blood pressure-related complications in order to 
increase adherence and decrease the risk of stroke and heart attack.  
Theoretical Framework 
The health belief model (HBM) is a psychological model that describes health behavior 
related to the disease condition as per patient perception. The HBM is one of the most commonly 
used models to understand health behavior. It is intended to motivate people with positive 
aspects related to their health condition and remove any negative behavior that impacts their 
health with maintenance of regular healthy behaviors. This model is useful in nursing and in 
other health care settings to modify patient behavior to improve the prognosis (Burke, Butt, 
Glanz, Rich, Rimmer & Stewart, 2017). This model anticipates that a patient’s health behavior is 
influenced by their beliefs and perception of the disease or condition; these beliefs create a threat 
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toward health that can be removed with health education (Burke, et al., 2017). Before applying 
this model, it is necessary to know about patient beliefs and the behaviors that hinder treatment 
plans. The HBM has the following six components: (a) perceived susceptibility, (b) perceived 
severity, (c) perceived benefit, (d) perceived barrier, (e) cues to action, and (f) self-efficacy 
(Burke, et al., 2017).  
The six components of HBM play an important role in changing patient behavior. The 
first component of HBM is perceived susceptibility. It is a persons’ perspective of becoming ill 
and understanding certain steps that are required to decrease the negative effects of the disease 
on their health. People usually do not accept their disease condition until they learn more about 
the risks and severity of disease (Tarkang & Zotor, 2015).  
The second component of HBM is perceived severity, which is the perception of severity 
and consequences related to disease. It does not mean that after perceiving susceptibility patients 
start taking action, but they must be aware of the serious and life threatening consequences 
related to the disease in order to take action. The HBM states that people will not change their 
health beliefs if they are unaware that hypertension can cause severe damage to their health 
(Tarkang & Zotor, 2015). 	
The next component of the HBM is perceived benefits, which refers to one’s belief that 
certain actions and health behavior can decrease the impact of a disease or condition (Tarkang & 
Zotor, 2015). For instance, patients must be aware of the benefits of hypertension medications as 
opposed to the side effects so they can start taking medication to control hypertension. In the 
perceived barrier component, a person believes behavior change could have negative impacts 
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(Tarkang & Zotor, 2015). For example, a hypertensive patient takes medication but when they 
run out, they must go to the doctor for the prescription and then to the pharmacy. It wastes their 
time or they may not have access to transportation. Removing the barriers of obtaining 
prescription refills may include using home delivery if there is a lack of transportation. If such 
barriers could be removed the negative impact on health can be minimized.  
 Tarkang and Zotor (2015) listed the second to last component as cues to action, which 
are the influences and behavior that motivate the patient to act according to the decision making 
process. For instance, this could involve providing a pill reminder so a patient can take 
medications on time. Cues to action work when patients are ready to take certain actions and are 
aware of the positive impact of the action on their health. Cues to action require an impulsive 
behavior and a willingness to complete certain actions that make a difference in their lives 
(Tarkang & Zotor, 2015).  
The last component is self-efficacy, which refers to individuals’ capacity to learn or apply 
what they learned to real life. The person removes all the difficulties in order to take the needed 
action and move forward (Tarkang & Zotor, 2015). For instance, if a patient is unable to receive 
medication due to a lack of transportation they will set up a home delivery system to receive 
medications on time. 
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Chapter 2: Literature Review 
Rimando (2015) used a qualitative descriptive design to study barriers and facilitators of 
hypertension management in underserved African American older adults. Rimando enrolled 28 
African American males and females recruited from a clinic in the Southeast. Participants met 
the study inclusion criteria if they were 55 years or older with hypertension, whether or not their 
hypertension was controlled. The author used semi-structured interviews to collect the qualitative 
data. The interview questions focused on knowledge related to hypertension, exercise, nutrition, 
stress management, and barriers to self-management of hypertension. The outcome variables 
were hypertension behavior, interaction with the healthcare provider, and social environment. 
Rimando analyzed the interview results to identify any themes present in the content and 
concluded that various factors influenced patients’ abilities to manage hypertension. The 
common identified factors were poor social status, lack of motivation, and fear of physical 
activity-related injuries. Facilitators helped the patients in hypertension control, such as support 
from society, family members diagnosed with hypertension or diabetes, and weight loss. This 
study helped identify social determinants that affect hypertension management. Rimando (2015) 
mentioned a limitation of the study was that participants might have responded about their 
hypertension self-management behaviors in a socially desirable way. Another limitation was that 
Rimando conducted the study at one clinic that excluded the entire urban population in the area; 
thus, the results are not generalizable to various clinics. 
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Holt et al. (2013) used a cross-sectional approach to study sex differences in barriers to 
antihypertensive medication adherence. The researchers enrolled 2,194 participants recruited 
from a large managed care organization in southeastern Louisiana. The participants were 65 
years and older with the diagnosis of essential hypertension. The authors collected data using the 
8-item Morisky medication scale. They evaluated the risk factors related to low adherence with 
the help of telephone surveys and administrative databases. In using the chi-square test to 
evaluate the low medication adherence between men and women, Holt et al. (2013) found no 
statistical significance. Using a sex-stratified multivariate model, the authors evaluated the 
association between a participant’s characteristics and medication adherence. The common 
factors related to a low adherence rate were medication costs and following limited lifestyle 
modifications to manage blood pressure. Decreased libido was the only factor determined to 
have a significant impact in men. On the other hand, the factors affecting only women were 
depressive symptoms and limited collaboration with the provider. A strength of the study was its 
large sample size and participant diversity. A limitation of the study was the fact that a large 
number of research participants did not respond to a sexual functioning question, which affected 
the results from other participants. 
Tong et al. (2016) used a stratified sampling method to study non-adherence to 
antihypertensive medication among hypertensive adults in the United States. The participants 
enrolled in the study with the help of a survey. The researchers sent a consumer style survey to 
20,000 individuals and 10,328 responded. Researchers sent a second healthy style survey to 
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6,253 individuals and received 4,198 responses. The authors used the univariate and multivariate 
logistic regression assessments to assess the correlation between non-adherence of medication 
and independent variables. Of the respondents with hypertension (27%), 30.5% were not 
adhering to their medications. A higher rate of non-adherence occurred among young Hispanic 
adults with low income and those diagnosed with depression (Tong et al., 2016). The most 
common barrier was inability to afford their medications (37.2%). One strength of the study was 
that the authors conducted the survey via mail, which reduced patients’ commute times. A 
limitation of the study was that it required English proficiency and the mailing addresses of the 
participants, which excluded all non-English-speaking and homeless individuals. 
Allen, Brownstein, Escoffery, and Satsangi (2016) used the qualitative and quantitative 
methods to study Community Health Workers (CHWs) as allies in hypertension self-
management and medication adherence in the United States. Allen et al. (2016) enrolled 265 
CHWs from 19 states with the help of an online survey and 23 telephone interviews. The 
participants had to be CHWs, older than 18 years, and fluent in English. The survey included 56 
Likert scale-based, multiple-choice, open-ended questions. The authors used a qualitative 
approach with 21 open-ended questions to evaluate the CHWs’ support of hypertensive patients. 
They transferred all data into SPSS version 22 for evaluation and analyzed the data with the help 
of a descriptive approach. They evaluated interviews using a thematic analysis. The CHWs 
explained that most of their roles were patient driven, and they used multiple strategies to reduce 
barriers in hypertensive patients. The CHWs were able to fill medications on time, which 
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reduced the barrier of the lack of refills. One strength of this study was its large sample size from 
19 states. One limitation of the study was the participation of only one type of healthcare team 
member (i.e., CHWs), which provided a narrow response.   
Hall, Lee, Clark, and Perilla (2014) used a cross-sectional correlational design to study 
adherence to hypertension treatment among Latino migrant and seasonal farmworkers (MSFWs). 
Hall et al. (2014) enrolled 45 MSFWs recruited from two farmworkers’ health clinics in the 
southeast region of the United States. The inclusion criteria for the study were MSFWs 20 to 60 
years old, who were diagnosed with hypertension in the past 6 months, and taking 
antihypertensive medications. The authors collected data with the help of the Morisky 
medication adherence scale, the blood pressure self-care scale, the blood pressure knowledge 
scale, the perceived stress scale, the acculturation rating scale for Mexican Americans-II, and a 
short assessment of health literacy for Spanish-speaking adults. They used descriptive statistics 
to analyze the data. The Morisky medication adherence scale showed a low medication 
adherence rate (51%). The blood pressure control indicated higher health literacy and 
acculturation among MSFWs. The blood pressure knowledge scale perceived that stress related 
to disease condition, acculturation, healthcare education, and availability of healthcare services 
affected 49% of the blood pressure self-care. A strength of the study was its evaluation of 
medication adherence using three types of variables (i.e., medication adherence, self-care, and 
blood pressure control). A limitation of the study was that it measured blood pressure control 
only on one occasion, which could have caused bias in blood pressure results. 
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Bazargan et al. (2017) used structured face-to-face interviews and visual inspections of 
participants’ medications to study non-adherence to medications among older African American 
adults. Bazargan et al. (2017) enrolled 400 individuals recruited from South Los Angeles. They 
conducted medication bag assessments for the evaluation of factors associated with medication 
adherence. They examined factors such as complex medication schedules, polypharmacy, 
duplication of medications, and use of incorrect medications. Two professional individuals 
conducted a visual inspection of medication bags. The authors evaluated individuals’ drug 
regimen complexity with the help of the medication regimen complexity index. They also used a 
descriptive analysis to evaluate the frequencies, mean, and standard deviations of the variables. 
Barzagan et al. (2017) examined the non-adherence of medication related to complex drug 
schedules with a chi-square test and evaluated the non-adherence association to demographic 
characteristics and various factors using multiple logistic regression. Participants took an average 
of 5.7 prescription drugs, and 56% of participants were not aware of the benefits of any 
medication. A limited number of participants knew the prescription strength of their medications. 
In addition, 37% of participants reported having stopped taking one of their prescription 
medications. The individuals with knowledge related to medication dosage, schedule, and 
benefits were seven times more likely to have medication adherence than individuals without this 
knowledge. Participants with less complicated medication treatment showed double the 
compliance rate than those with more complex medication schedules. The multivariate analysis 
indicated an association between low medication adherence and copayments, knowledge about 
the medication, and memory deficits. One strength of the study was its large sample size. A 
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limitation of the study was its examination of only patient-related factors, leading to narrow 
results. The authors should have also evaluated providers to measure barriers related to patients’ 
medication non-adherence. 
Polanski et al. (2014) used a qualitative design to study patients’ barriers related to 
primary medication adherence. Polanski et al. enrolled 26 patients recruited from Northeastern 
states. The eligibility criteria were age greater than 25 years and not having picked up any 
hypertensive medications within 30 days of their refill dates. The authors asked the participants 
questions based on three different types of focus group discussions: (a) perceptions of the 
hypertension diagnosis and hypertension medications; (b) barriers causing noncompliance, such 
as medication side effects, transportation issues, and personal and cultural beliefs; and (c) 
decisions related to medication administration and the patient-provider relationship. The authors 
employed a descriptive analysis to analyze demographic data and a thematic analysis to analyze 
focus group answers. The common factors affecting patients’ perceptions were distrust of 
medication, anger regarding the disease condition, and suspicion of the provider. The identified 
barriers were fear of side effects, higher costs of medications, lack of transportation, and 
confusion about generic medications. The patients wanted detailed conversations with their 
providers and hoped for trustworthy relationships with their caregivers. One strength of the study 
was the diversity of participants selected from the three Northeastern states. A limitation of the 
study was the patient selection on a volunteer basis, which excluded all patients who had refilled 
their medications on time. 
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Chapter 3: Methodology 
Participants 
 The research began after receiving Internal Review Board (IRB) approval from Fresno 
State University and permission from an urban urgent care clinic. This researcher adopted a 
quantitative and qualitative mixed approach that included 30 participants who were conveniently 
sampled. The inclusion criteria for the participants were that they were between 45 and 60 years 
old with a diagnosis of hypertension and were taking one or more antihypertensive medications. 
Recruitment occurred at the urgent care clinic when patients made general visits during open 
business hours. The rationale for selecting this location was the fact that the researcher saw, on 
average, 5 to 10 hypertensive patients per day. The researcher selected volunteer participants 
from those individuals who showed interest and were willing to sign a consent form. This 
approach ensured diversity throughout the participant population, as the urgent care clinic is a 
multicultural clinic.  
Sampling Procedures 
The research study was open from September 14, 2018 to October 30, 2018. The 30 
participants were recruited during regular visits to the urban urgent care clinic. The researcher 
used the convenience sampling method for recruitment. The inclusion criteria of the study were: 
(a) participants were between 45-60 years of age and English speaking, (b) diagnosed with 
hypertension, and (c) taking one or more hypertensive medications to control high blood 
pressure. The exclusion criteria were (a) non-hypertensive patients, (b) patients younger than 45 
years and older than 60 years, (c) gestational hypertensive patients, (d) population outside of 
urban urgent care, (e) individuals with co-morbidities, and (f) non-English speaking. The 
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researcher explained the procedure as well as all disclosures to the patients. The research 
participants were asked to sign a consent form to participate in the study. The participants were 
free to withdraw from the research study at any time by simply removing their consent forms.  
Research Design 
The research design for this study included a mixed quantitative and qualitative method. 
The researcher collected quantitative data using demographic questions alongside the Morisky 
Green Levine scale (MGL) (Morisky, Green, & Levine, 1986). The MGL test is a public use 
scale, so no permission was required to adopt it for the research study. The demographic 
questions were created by the researcher to collect data regarding participant demography and 
included questions on ethnicity, primary language spoken, age, and gender. The MGL questions 
were: (a) “Do you ever forget to take your medicine?” (b) “Are you careless at times about your 
medicine?” (c) “When you feel better, do you sometimes stop taking your medicine?” and (d) 
“Sometimes you fell worse, when you take the medicine, do you stop taking it?” The researcher 
used chi-square tests of association to evaluate the significant relationship between number of 
barriers and non-adherence. The researcher also evaluated the relationship between ethnicity and 
non-adherence. The chi-square test is singularly effective in evaluating relationships between 
two categorical variables (Heavey, 2015).  
The qualitative data were collected with the utilization of the following four open-ended 
questions: (a) “What are your reasons for not taking your medications? List any three.” (b) 
“What are your reasons for not filling your prescriptions on time? List any three.” (c) “What are 
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the reasons for not visiting your primary care physician? List any three.” (d) “What helps you 
take your medications? List any three reasons.” These questions were created after the literature 
review setting in order to explore more deeply the different barriers causing non-adherence to 
hypertension treatment plans. The researcher used a thematic approach to the data analysis in 
order to elaborate upon various barriers related to medication adherence. The quantitative data 
was transferred to SPSS version 24. The qualitative data was transferred to NVIVO 12.	The 
researcher reevaluated the data to ensure accurate results. The researcher locked all data in a 
secured electronic file, limiting access to the researcher only. After transferring results to SPSS 
and NVIVO 12 the researcher shredded the questionnaires.   
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Chapter 4: Results 
Quantitative Data Analysis 
The quantitative data were evaluated in SPSS version 24 using descriptive statistics. A 
chi-square test of association was also used to evaluate the relationship between number of 
barriers and non-adherence and the relationship between ethnicity and non-adherence. 
Participants 
Thirty participants were included in the research study based on the inclusion and 
exclusion criteria. The frequencies and percentages for the participants’ demographic 
characteristics appear in Table 1. The largest percentages of participants were female (53.3%, n 
= 16), Asian (36.7%, n = 11), 55-60 years of age (46.7%, n = 14), and English as a first language 
(33.3%, n = 10). The bar charts for these demographics appear in Figures 1, 2, 3, and 4.  
Table 1 
Frequencies and Percentages of the Participants’ Demographic Characteristics 
Demographic N % 
Ethnicity   
Hispanic 7 23.3 
Caucasian 5 16.7 
African American 4 13.3 
Asian 11 36.7 
Others 3 10.0 
Total 30 100.0 
Age   
45-50 years 6 20.0 
50-55 years 10 33.3 
55-60years 14 46.7 
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Total 30 100.0 
Gender   
Male 14 46.7 
Female 16 53.3 
Total 30 100.0 
Language   
English  10 33.3 
Spanish 7 23.3 
Chinese 2 6.7 
Korean 1 3.3 
Hindi 4 13.3 
Other 6 20.0 
Total 30 100.0 
 
 
Figure 1. Percentages for participants’ ethnicity.  
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Figure 2. Percentages for participants’ age.  
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Figure 3. Percentages for participants’ gender. 
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Figure 4. Percentages for participants’ language.  
 
Frequencies and Percentages for Medication Adherence (Morisky's Scale Scores) and 
Number of Barriers (Questions 9 and 10) 
As seen in Table 2, the largest percentage of participants had medium medication 
adherence (50%, n = 15). The greatest percentage of participants had 11-12 barriers (46.7%, n = 
14) and the lowest percentage of participants had 3-4 barriers (10%, n = 3) and 5-6 barriers 
(10%, n = 3). The bar charts for medication adherence and barriers appear in Figures 5 and 6. 
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Table 2 
Frequencies and Percentages of Medication Adherence (Morisky's Scale Scores) and Number of 
Barriers 
Variable  N % 
Morisky's scale score    
Less than 2 (low adherence) 9 30.0 
2 or 3 (medium adherence) 15 50.0 
greater than 3 (high adherence) 6 20.0 
Total 30 100.0 
 
Number of barriers   
3-4 3 10.0 
5-6 3 10.0 
7-8 4 13.3 
9-10 6 20.0 
11-12 14 46.7 
Total 30 100.0 
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Figure 5. Percentages for medication adherence. 
Figure 6. Percentages for barriers. 
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Results of the chi-square test of association 
The relationship between number of barriers and medication adherence. A chi-
square test of association was used to evaluate the relationship between number of barriers and 
medication adherence. The assumption that cells have expected counts greater than five was met.   
The crosstabs of observed counts for number of barriers and medication adherence appear 
in Table 3.  There was a significant relationship between number of barriers and medication 
adherence, Χ2 (8) = 42.86, p = < .05, Cramer’s V = .85. The effect size for the relationship 
between number of barriers on medication adherence was assessed via the Cramer’s V value of 
.85, which corresponds to a large effect size.  
Those with 11-12 barriers (n = 9) had low adherence. Those with 9-10 barriers (n = 6) 
and 7-8 barriers (n = 4) had medium adherence. Those with 5-6 barriers (n = 3) and 3-4 barriers 
(n = 3) had high adherence. This data indicates that a greater number of barriers was associated 
with lower adherence in hypertensive patients. Given these findings, the null hypotheses that 
there is no relationship between the number of barriers and medication adherence was rejected. 
Table 3 
Crosstabs of Observed Counts for Number of Barriers and Medication Adherence (Morisky's 
Scale Score) 
Number of barriers Less than 2 (low 
adherence) 
2 or 3 (medium 
adherence) 
greater than 3 (high 
adherence) 
Total 
3-4 0 0 3 3 
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5-6 0 0 3 3 
7-8 0 4 0 4 
9-10 0 6 0 6 
11-12 9 5 0 14 
Total 9 15 6 30 
 
 
Figure 7. Frequencies of number of barriers by and medication adherence. 
The relationship between ethnicity and medication adherence. A chi-square test was 
also used to evaluate the relationship between ethnicity and medication adherence. The 
assumption that cells have expected counts greater than five was met.   
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The crosstabs of observed counts for ethnicity by medication adherence appear in Table 
4. The relationship between ethnicity and medication adherence was not statistically significant, 
Χ2 (8) = 4.56, p = > .05, Cramer’s V= .27. The effect size for the relationship between ethnicity 
and medication adherence was indicated by the Cramer’s V value of .27, which corresponds to a 
moderate effect size.  
The chi-square test of association was not statistically significant. Given these findings, 
the null hypotheses that there is no relationship between ethnicity and medication adherence was 
accepted.	
	Table 4 
Crosstabs of Observed Counts for Ethnicity by Medication Adherence (Morisky's Scale Score) 
Ethnicity Less than 2 (low 
adherence) 
2 or 3 (medium 
adherence) 
greater than 3 
(high adherence) 
Total 
Hispanic 2 3 2 7 
Caucasian 1 3 1 5 
African American  1 1 2 4 
Asian 4 6 1 11 
Others 1 2 0 3 
Total 9 15 6 30 
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Figure 8. Frequencies of ethnicity by and medication adherence. 
 
Qualitative Results 
Qualitative Data Analysis and Coding 
 The researcher’s objective was to identify factors relevant to four research questions as 
reflected in open-ended survey responses from 30 research participants. The qualitative data 
analysis was completed in NVIVO 12. Common themes were identified across the data with 
regard to reasons for not taking medications, reasons for not filling medication prescriptions, 
reasons for not visiting the Primary Care Physician (PCP), and what helps individuals take their 
medications.   
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 The process of data analysis involves “making sense out of text and data…and preparing 
the data for analysis, conducting different analyses, moving deeper and deeper into 
understanding the data, representing the data, and making an interpretation of the larger meaning 
of the data” (Creswell, 2009, p. 183). The researcher looked for themes and patterns in the data 
through analysis of the responses to the open-ended questions, coding of the data, and further 
analysis as themes and patterns emerged. The researcher’s goal was to describe the participants’ 
views as reflected in the data.  
 The first level of identification occurred during the initial review of the qualitative data. 
Upon receiving the qualitative data, the researcher read the responses, analyzed the open-ended 
question responses, and then conducted open coding utilizing NVIVO software, which is an 
analytic tool to facilitate the coding process. During open coding, the researcher utilized a 
brainstorming technique described by Corbin and Strauss (2008) to “open up the data to all 
potentials and possibilities contained within them” (p. 160). In open coding, the researcher 
thoroughly reviews the data contained within the data set before beginning to group and label 
data.  The process of coding is taking the raw data and pulling out concepts and then further 
developing them in terms of their properties and dimensions, and grouping them into themes. 
The data analysis process included the following steps: 
1. Review all open-ended qualitative data. 
2. Import the data into NVIVO. 
3. Code the data in NVIVO using open coding. 
4. Define the properties of the themes. 
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The resulting themes are described in the summary of the research findings.  
 The coding process identified a total of 23 themes. The themes were delineated into the 
following four areas: (a) reasons for not taking medications, (b) reasons for not filling 
medication prescriptions, (c) reasons for not visiting the Primary Care Physician (PCP), and (d) 
what helps individuals take their prescribed medications. The findings for each area are 
summarized and examples from the participant responses are used to illustrate the themes.  
Participants’ Reasons for not Taking Medications 
 The themes related to participants’ reasons for not taking medications are summarized in 
this section. This section includes a table summarizing the identified themes and the frequency of 
occurrence for the themes. As reflected in Table 5, the primary themes were (a) lack of time is a 
barrier to taking medications, (b) some individuals do not want to take the prescribed 
medications, (c) side effects are a barrier to taking medications, (d) forgetfulness is a barrier to 
taking medication, and (e) cost of medication is a barrier to obtaining and taking medications. 
Table 5 
Themes and Frequencies of Themes for Participants’ Reasons for not Taking Medications 
Theme # of times the theme appeared   
Lack of time is a barrier to taking medications 26 
Some individuals do not want to take the prescribed 
medications 
23 
Side effects are a barrier to taking medications 21 
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Forgetfulness is a barrier to taking medication 18 
Cost of medication is a barrier to obtaining and taking 
medications 
3 
 
Lack of time is a barrier to taking medications. The most frequently occurring theme 
for this area was lack of time was a barrier to taking medications. This theme was mentioned 26 
times. For example, a participant wrote, “I am busy.” Another wrote “No time because I am busy 
with work.” In a final example, a participant wrote, “busy.”  
Some individuals do not want to take the prescribed medications. The next theme 
was some individuals do not want to take the prescribed medication; it was mentioned 23 times. 
A participant wrote, “I do not want to take it.” Others indicated, “I do not want to take 
medication” and “I do not want to take for lifetime.” In a final example of this theme, a 
participant shared, “I do not want to stick with the medication. I think I am ok without 
medication.” 
Side effects are a barrier to taking medications. The next theme for this area was side 
effects are a barrier to taking medications. It was mentioned 21 times. Approximately 20 
participants simply wrote “Side-effects.” One participant indicated, “Too many medications. 
Side effects.” 
Forgetfulness is a barrier to taking medication.	The next theme for this area was 
forgetfulness is a barrier to taking medication. It was mentioned 18 times. A participant wrote, “I 
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usually forget to take my medications.” Another shared, “Forgetting due to work hours.” Other 
wrote things like “Forget” or “Sometime I forget to take medication.” 
Cost of medication is a barrier to obtaining and taking medications. The final theme 
for this area was cost of medication is a barrier to obtaining and taking medications. This theme 
was mentioned three times. Participants indicated, “Expensive medication, “Expensive,” and 
“Cost issues.” 
Participants’ Reasons for not Filling Medication Prescriptions 
 The themes related to participants’ reasons for not filling medication prescriptions are 
summarized in this section. This section includes a table summarizing the identified themes and 
the frequency of occurrence for the themes. As reflected in Table 6, the primary themes were (a) 
the cost of medication is too high for those with copays or lack of insurance, (b) not having 
transportation to get to a pharmacy is a barrier to filling medication prescriptions, (c) some 
individuals avoid and do not want to see the doctor to obtain a medication refill, (d) individuals 
indicate that refills are unavailable, and (e) individuals forget to fill the prescription. 
Table 6	
Themes and Frequencies of Themes for Participants’ Reasons for not Filling Medication 
Prescriptions 
Theme # of times the theme appeared   
The cost of medication is too high for those with copays 
or lack of insurance 
19 
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Not having transportation to get to a pharmacy is a 
barrier to filling medication prescriptions 
12 
Some individuals avoid and do not want to see the doctor 
to obtain a medication refill 
8 
Individuals indicate that refills are unavailable 7 
Individuals forget to fill the prescription 3 
 
The cost of medication is too high for those with copays or lack of insurance. The 
most frequently occurring theme for this area was that the cost of medication is too high for 
those with copays or lack of insurance. It was mentioned 19 times. Participants wrote responses 
such as, “No insurance” or “Lack of insurance.” Several others wrote, “High co-pay.” Other 
participants’ responses were “Cost,” “No money,” “Expensive medications,” and “Expensive.” 
Not having transportation to get to a pharmacy is a barrier to filling medication 
prescriptions. The next theme was that not having transportation to get to a pharmacy is a 
barrier to filling medication prescriptions. This barrier to filling medication prescriptions was 
mentioned 12 times. Participants indicated, “I do not drive” and “No transportation,” which is a 
barrier to filling medications.  
Some individuals avoid and do not want to see the doctor to obtain a medication 
refill. The next theme was that some individuals avoid and do not want to see the doctor to 
obtain a medication refill. This barrier of medication refill was mentioned eight times. 
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Participants wrote the following: “I do not want see my doctor,” “I do not want to visit my 
doctor,” and “I do not want to make an appointment to see my doctor.” 
Individuals indicate that refills are unavailable. The next theme for this area was that 
individuals indicate that refills are unavailable. This was mentioned seven times. Seven 
participants indicated this barrier by writing, “No available refills.”  
Individuals forget to fill the prescriptions. The final theme for this area was that 
individuals forget to fill the prescriptions. This theme was mentioned three times. Participants 
wrote the following, which are indicative of this theme: “Forget to refill,” “No refill available,” 
and “Forget.”  
 
Participants’ Reasons for not Visiting the Primary Care Physician (PCP)  
The themes related to participants’ reasons for not visiting the PCP are summarized in 
this section. This section includes a table summarizing the identified themes and the frequency of 
occurrence for the themes. As reflected in Table 7, the primary themes were (a) lack of available 
appointments is a barrier to visiting the PCP, (b) individuals' schedules are a barrier to 
scheduling an appointment with the PCP, (c) individuals lack transportation to get to the PCP, 
(d) individuals feel they do not need to see the PCP, (e) lack of health insurance prevents PCP 
visits, and (f) long wait times are a barrier to visiting the PCP. 
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Table 7 
Themes, Definitions, and Frequencies of Themes for Participants’ Reasons for Not Visiting the 
PCP 
Theme # of times the 
theme appeared 
Lack of available appointments is a barrier to visiting the PCP 22 
Individuals' schedule is a barrier to scheduling an appointment with the PCP 15 
Individuals lack transportation to get to the PCP 10 
Individuals feel they do not need to see the PCP 10 
Lack of health insurance prevents PCP visits 8 
Long wait times are a barrier to visiting the PCP 4 
   
Lack of available appointments is a barrier to visiting the PCP. The most frequently 
occurring theme for this area was lack of available appointments is a barrier to visiting the PCP. 
This barrier to visiting the PCP was mentioned 22 times. Seven people wrote, “Unavailable 
appointments.” Fifteen individuals indicated, “No appointment available according to my work 
schedule” or “Doctor’s appointment is unavailable.” 
Individuals' schedules are a barrier to scheduling an appointment with the PCP. 
The next theme was individuals' schedules are a barrier to scheduling an appointment with the 
PCP. This barrier was mentioned 15 times. For example, individuals indicated the following: 
“Busy schedule,” “Busy schedule unable to make appointment,” and “Very busy with work.”  
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Individuals lack transportation to get to the PCP. The next theme for this area was 
individuals lack transportation to get to the PCP. It was mentioned 10 times. Participants 
indicated they had “No transportation.” Some said the PCP was “Very far.” 
Individuals feel they do not need to see the PCP. The next theme for this area was 
individuals feel they do not need to see the PCP. It was mentioned 10 times. Some said, “I do not 
need to see the PCP” or “I think I do not need to see my doctor.” One indicated, “Feeling better.” 
A few said they did not need to see the PCP because of “Normal blood pressure” or “Blood 
pressure is good.”  
Lack of health insurance prevents PCP visits. The next theme for this area was lack of 
health insurance prevents PCP visits. It was mentioned eight times. Participants indicated they 
lacked or had no insurance and that they could not afford “Expensive visits.” 
Long wait times are a barrier to visiting the PCP. The final theme for this area was 
long wait times are a barrier to visiting the PCP. This theme was mentioned four times. The 
participants indicated “Long wait time” and “Wait time is long.” 
What Helps Individuals Take Their Prescribed Medications 
The themes related to what helps individuals take their prescribed medications are 
summarized in this section. This section includes a table summarizing the identified themes and 
the frequency of occurrence for the themes. As reflected in Table 8, the primary themes were (a) 
reminders facilitate remembering to take medications, (b) home delivery of medications 
facilitates taking medications, (c) the ability to obtain refills helps individuals take medications 
(d) medications improve health and this helps individuals take the medications, (e) appointments 
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with the PCP facilitates taking medications, (f) access to affordable medications helps 
individuals take medications, and (g) having transportation to the pharmacy to fill prescriptions 
helps individuals take their medications. 
Table 8 
Themes and Frequencies of Themes for What Helps Individuals Take Their Prescribed 
Medications 
Theme # of times the 
theme appeared 
Reminders facilitate remembering to take medications 27 
Home delivery of medications facilitates taking medications 18 
The ability to obtain refills helps individuals take medications 15 
Medications improve health and this helps individuals take the medications 5 
Appointments with the PCP facilitates taking medications 2 
Access to affordable medications helps individuals take medications 2 
Having transportation to the pharmacy to fill prescriptions helps 
individuals take their medications 
1 
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Reminders facilitate remembering to take medications. The most frequently occurring theme 
for this area was reminders facilitate remembering to take medications. This was mentioned 27 
times. For example, many mentioned “Pill reminders,” “Medicine on the table,” or “Pill box with 
me.” 
Home delivery of medications facilitates taking medications. The next theme was 
home delivery of medications facilitates taking medications. This theme was mentioned 18 times 
by 18 participants who wrote “Home delivery.” 
The ability to obtain refills helps individuals take medications. The next theme was 
the ability to obtain refills helps individuals take medications. This theme was mentioned 15 
times. For this theme, participants wrote that the availability of refills helped them take their 
medications. They simply wrote “Available refills.” 
Medications improve health and this helps individuals take the medications. The 
next theme was medications improve health and this helps individuals take the medications. This 
theme was mentioned five times. Participants wrote that “Knowing my health is improved” and 
“Knowing it is important so I can feel better” helped them take their medications. 
Appointments with the PCP facilitates taking medications. The next theme was 
appointments with the PCP facilitates taking medications. This theme was mentioned two times. 
Participants wrote that an “Available appointment” with the PCP facilitated taking medications. 
Access to affordable medications helps individuals take medications. The next theme 
for this area was access to affordable medications helps individuals take medications. It was 
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mentioned twice. The two participants wrote that “Cheap medication” helped them take the 
medication. 
Having transportation to the pharmacy to fill prescriptions helps individuals take 
their medications. The final theme for this area was having transportation to the pharmacy to fill 
prescriptions helps individuals take their medications. This theme was mentioned once by a 
participant who indicated she/he would take the medication “If I have ride to pharmacy.”  
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Chapter 5: Discussion 
 The goal of this project was to identify the barriers causing non-adherence to 
hypertension treatment plans among individuals 45 to 60 years of age. The findings of this 
research study corresponded to the findings of the research studies summarized in the literature 
review. Tong et al. (2016) identified common barriers resulting in non-adherence to hypertensive 
medications. One of the main barriers for the patients was affordability of the medications due to 
socioeconomic status. The findings of this project were similar to Tong et al.’s findings that lack 
of insurance and patients’ affordability due to socioeconomic status were also barriers. Hall et al. 
(2014) concluded the lower the number of the Morisky 8-Item Medication Adherence 
Questionnaire, the higher the non-adherence rate in hypertensive patients. In this pilot study, the 
researcher also found medication non-adherence rates similar to those of Hall et al.; however, 
the researcher used the Morisky Green Levine Scale. Researchers used the validated scale to 
evaluate patients’ medication adherence. 
 Barzagan et al. (2017) found that medication non-adherence was caused by high co-
payments. The researcher also found similar barriers with the help of open-ended questions. 
These barriers included affordability of medications and visits due to socioeconomic status. A 
study by Polanski and colleagues (2014) identified the barriers as medication side effects and 
transportation issues. In this research study, patients also listed similar barriers of non-adherence 
such as side effects of medications and lack of transportation.  
 This research study also included questions that help individuals to take their prescribed 
medications, which were not found in the literature review. There were multiple responses 
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collected from the patients which include: (a) reminders facilitate remembering to 
take medications, (b) home delivery of medications facilitates taking medications, (c) the ability 
to obtain refills helps individuals take medications, (d) medications improve health and this helps 
individuals take their medications, (e) appointments with the PCP facilitates taking medications, 
(f) access to affordable medications helps individuals take medications, and (g) having 
transportation to the pharmacy to fill prescriptions helps individuals take their medications. 
Limitations 
 This research project had several limitations. The first limitation was the nominal sample 
size. This study was performed at Urban Urgent Care clinic which excluded individuals who did 
not come to this urgent care clinic for treatment. Due to the nominal sample size, the results 
cannot be generalized to a larger population. The second limitation of this study was the use of 
the Morisky Green Levine scale to measure adherence rates. This scale has fewer questions as 
compared to the Morisky 8-Item Medication Adherence Questionnaire.  
 The third limitation of this study was the use of open-ended questions, in which patients 
were asked to list three barriers that caused non-adherence to hypertensive medications. Some 
patients may have had more than three barriers to list. They were unable to list more barriers 
because the researcher only asked for three to be listed. Requesting that participants list more 
barriers may have revealed additional reasons for medication non-adherence.  
Recommendations for Future Research 
This research study was a pilot study with a nominal sample size. The study included a 
patient population from only one Urban Urgent Care Clinic; individuals who did not come to 
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this clinic for treatment were excluded. Future studies can be done with a larger sample size by 
using a more detailed questionnaire to identify various barriers that cause non-adherence to 
hypertensive treatment plans. The results of a study that includes a larger sample size could 
be generalized to the patient population to implement further interventions. Future research can 
also instruct the patients to list more than three barriers which would be helpful in exploring 
what else is causing non-adherence to their hypertension medication management.  
Implications for Nursing Practice 
The common reason for uncontrolled hypertension is treatment non-adherence (CDC, 
2017). Treatment non-adherence refers to patients not following their treatment plans as given by 
their providers (CDC, 2017). The goal of this pilot study was to identify barriers that contribute 
to hypertensive medication non-adherence. The researcher found multiple barriers including side 
effects, forgetfulness, lack of time, lack of insurance, unavailable appointments, and lack of 
transportation. The results of the pilot study can be used to educate clinicians, nurse 
practitioners, and nurses regarding the barriers that cause non-adherence to hypertensive 
medications. In the future, clinicians and nursing staff can implement interventions to decrease 
these barriers. For instance, patients indicated they were unable to pick up medication due to a 
lack of available transportation. These patients can be advised to use home delivery 
methods. Medication adherence will help nurses to achieve the goal of Healthy People 2020, 
which is to increase prevention of heart disease and stroke, as well as improve patients’ 
cardiovascular health. 
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The study done by Iuga and McGuire determined that the cost of medication adherence 
related to disease management is less than the cost of hospitalization due to non-adherence. 
Medication adherence helps to decrease the impact of emergent cases in hospitals and urgent 
care clinics. It further helps to lower the cost of diagnostic evaluation during emergency visits. It 
also decreases the impact of complications related to hypertension, which are stroke and heart 
diseases. This pilot study will decrease the patient load in the emergency room and increase the 
quality of patient care by reducing the number of patients. 
Conclusion 
This project was a mixed methods pilot study to identify various barriers that cause non-
adherence to hypertensive medication management. The quantitative data was analyzed with the 
help of the Morisky Green Levine scale, which showed the medication non-adherence rate was 
greater when the scale score numbers were lower. The quantitative data was evaluated in SPSS 
version 24 using descriptive statistics. A chi-square test of association was utilized to evaluate 
the association between the non-adherence rate and the number of barriers. The test results 
revealed there was a relationship between medication non-adherence rate and number of barriers. 
The greater the barrier, the higher the non-adherence rate. A chi-square test was also used to 
evaluate the relationship between ethnicity and medication non-adherence rate and results 
revealed that there was no relationship between medication non-adherence rate and ethnicity. 
The non-adherence rate was the same in all patient ethnic groups.  
The qualitative analysis included the analysis of data from open-ended questions. The 
data was analyzed in NVIVO to identify barriers related to hypertensive medication non-
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adherence. The researcher identified multiple barriers, which were consistent with literature 
review findings. The common barriers were lack of time, side effects, forgetfulness, cost of 
medications, lack of insurance, lack of transportation, unavailable refills, and a long wait time. 
Further research is required to understand how to reduce these barriers to increase hypertensive 
patient adherence to their medication regimen.  
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Informed Consent 
You are invited to participate in a study. We hope to identify what prevents people from 
taking their blood pressure pills. The approved study will be conducted by Navpreet Kaur. This 
study will be run through Action Urgent Care (AUC). The director of AUC has approved this 
project. In this research study, we will be taking patients with high blood pressure. The study 
will help us find things that are getting in the way of you taking your medications. There are no 
direct benefits to the participants of this study. You may see indirect benefits in the future to be 
aware of what is preventing you from not taking your pills.  
You were chosen as a possible participant in this study based off three criteria. 1) You 
have high blood pressure, 2) You are taking one or more pills for high blood pressure, and 3) 
You fall under age group 45-60 years. If you agree to participate in this research study, the 
researcher will provide you with a list of questions. There are no physical risks related to this 
research study. There is a possibility that some of the questions can hurt your feelings. It can 
increase the participants’ mental stress. The involvement in this study is your decision. It will not 
affect your rights or care at AUC. You are free to remove your consent any time. There is no 
penalty for removing consent.  
The study will help the researcher to know the struggles in high blood pressure treatment. 
The information will be kept strictly private. Only research personnel will have access to 
patient’s information. All files will be safe and locked away. After completing the study, all of 
the information will be destroyed. The Committee for the Protection of Human Subjects at 
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California State University Fresno has reviewed and approved the present research.   
  If you have any questions at any time, please ask us. Navpreet Kaur FNP-C (408-645-
7096) will be happy to answer them. Questions about the rights of the subjects may be directed 
to Dr. Kris Clarke, Chair, CSU Fresno Committee on the Protection of Human Subjects, (559) 
278-2985.   
 
YOUR SIGNATURE INDICATES THAT YOU HAVE DECIDED TO PARTICIPATE, 
HAVING READ THE INFORMATION PROVIDED ABOVE. YOUR PARTICIPATION IS 
PURELY VOLUNTARY. YOU CAN ALSO REMOVE YOURSELF AT ANY TIME FROM 
THIS STUDY. 
 
Date                                                                                       Signature  
_________________________________________________________  
Relationship to Subject  
 
 
 _________________________________________________________  
                                
Signature of Witness                                                       Signature of Investigator  
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APPENDIX B: PARTICIPANT QUESTIONS 
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Questions for Participants 
What is your ethnicity?  
What is your primary language?  
What is your Age?  
Gender? 
 
Answer yes or No 
1) Do you ever forget to take your medication?  
2) Are your careless at times about taking your medication?  
3) When you feel better do you sometimes stop taking your medications? 
4) Sometimes you fell worse, when you take the medication, do you stop taking 
medications?  
 
Please Elaborate your answers 
1) What are reasons of not taking medication? List any three.  
 
2) What are reasons of not filling prescriptions on time? List any three.  
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3) What are the reasons you are not visiting your primary care physician? List any three.  
 
4) What is helping you to take your medications? List any three reasons.	
 
